Viewing Study NCT00990405


Ignite Creation Date: 2025-12-25 @ 3:31 AM
Ignite Modification Date: 2026-01-24 @ 8:05 AM
Study NCT ID: NCT00990405
Status: UNKNOWN
Last Update Posted: 2009-10-06
First Post: 2009-10-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Study to Evaluate the Efficacy and the Safety of Eradication Therapy for Helicobacter Pylori in Functional Dyspepsia
Sponsor: Korean College of Helicobacter and Upper Gastrointestinal Research
Organization:

Study Overview

Official Title: Phase 4 Study of Helicobacter Pylori Eradication Therapy
Status: UNKNOWN
Status Verified Date: 2009-10
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The role of Helicobacter pylori infection in functional dyspepsia remains controversial. Several randomized controlled trials in western countries have shown no significant advantage over placebo. But some recent studies in Asian population were different compared to the result of studies in the Western population. At the present time, it seems to be difficult to conclude the efficacy of the H.pylori eradication therapy in patients with H. pylori-infected functional dyspepsia.

The investigators hypothesize that eradication of Helicobacter pylori has a sustained global symptom improvement in patients with H. pylori infected functional dyspepsia.
Detailed Description: Functional dyspepsia: diagnosed by Rome III criteria of Functional gastrointestinal disorder Treatment regimen: Combination of proton pump inhibitor, Amoxicillin, Clarithromycin for 7 days Placebo: Same shaped placebo drugs

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: